UNIVEST FINANCIAL Corp Sells 11,678 Shares of Agilent Technologies, Inc. (NYSE:A)

Key Points

• UNIVEST FINANCIAL Corp reduced its holdings in Agilent Technologies by 59.6%, selling 11,678 shares in the first quarter and ending with 7,909 shares valued at approximately $925,000.
• Agilent Technologies recently declared a quarterly dividend of $0.248 per share, translating to an annualized yield of 0.9% with a payout ratio of 24.44%.
• Analysts have diverse ratings on Agilent's stock, with a consensus target price of $139.77 indicating a "Moderate Buy" rating, while TD Cowen raised their price target to $150.00.

UNIVEST FINANCIAL Corp lessened its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 59.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,909 shares of the medical research company's stock after selling 11,678 shares during the quarter. UNIVEST FINANCIAL Corp's holdings in Agilent Technologies were worth $925,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of A. Redwood Park Advisors LLC acquired a new stake in Agilent Technologies in the 4th quarter worth $27,000. Sunbelt Securities Inc. grew its position in Agilent Technologies by 640.0% in the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock worth $30,000 after purchasing an additional 192 shares during the last quarter. Whipplewood Advisors LLC grew its position in Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after purchasing an additional 186 shares during the last quarter. Wood Tarver Financial Group LLC acquired a new stake in Agilent Technologies in the 4th quarter worth $34,000. Finally, Opal Wealth Advisors LLC acquired a new stake in Agilent Technologies in the 1st quarter worth $31,000.

Insider Buying and Selling

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Agilent Technologies Price Performance

NYSE:A opened at $113.51 on Friday. The firm has a market cap of $32.24 billion, a PE ratio of 28.03, a price-to-earnings-growth ratio of 3.48 and a beta of 1.22. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The company's 50-day moving average price is $117.08 and its two-hundred day moving average price is $120.79.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company's revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.22 earnings per share. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st were given a $0.248 dividend. The ex-dividend date was Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.9%. Agilent Technologies's payout ratio is 24.44%.

Analyst Ratings Changes

Several analysts have issued reports on A shares. TD Cowen raised their price target on shares of Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. UBS Group decreased their target price on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. Evercore ISI lifted their target price on shares of Agilent Technologies from $125.00 to $130.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Jefferies Financial Group decreased their target price on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Finally, Barclays lifted their target price on shares of Agilent Technologies from $115.00 to $125.00 and gave the company an "equal weight" rating in a research report on Tuesday, June 24th. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $139.77.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.